Emerging in the field of obesity therapy, retatrutide represents a different approach. Unlike many current medications, retatrutide works as a double agonist, at once engaging both GLP-like peptide-1 (GLP-1) and https://rebeccaibgd508393.blog-eye.com/38954295/the-novel-retatrutide-this-glp-gip-sensor-agonist